I get the result. If the result is good enough to have it divested to another group for significant use, however, I am all for it. I think this company is all about medical devices and CC going forward. For the next few years at least.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-60
-
- There are more pages in this discussion • 291 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.71 |
Change
-0.640(3.49%) |
Mkt cap ! $348.5M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $17.55 | $108.7K | 6.074K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 575 | $17.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.88 | 46 | 3 |
View Market Depth
| Last trade - 13.01pm 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |